NCT03441854View on ClinicalTrials.gov

High-Flow Nasal Cannula Versus Conventional Oxygen Therapy After Extubation in Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

September 30, 2018

Study Completion Date

December 31, 2018

Conditions
Gas Exchange
Interventions
DEVICE

HFNC group

Application of HFNC oxygen delivery after extubation.

Trial Locations (1)

00168

Fondazione Policlinico Gemelli, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03441854 - High-Flow Nasal Cannula Versus Conventional Oxygen Therapy After Extubation in Liver Transplantation | Biotech Hunter | Biotech Hunter